Assignee
RESOLVE THERAPEUTICS LLC
US·3 granted patents·6 pending applications·8 citations·filing 2014–2024
Top patents by PatentIndex Score
9 records- 0182US10988745B2Therapeutic nuclease-albumin fusions and methodsRESOLVE THERAPEUTICS LLC·Filed 2014·Granted Apr 27, 2021·8 cites·54 claims
- 0276US2025002885A1Optimized binuclease fusions and methodsRESOLVE THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0376US2025002884A1Optimized binuclease fusions and methodsRESOLVE THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0474US2025129349A1Nucleic acid molecules encoding nuclease-albumin fusion proteinsRESOLVE THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0569US12077790B2Optimized binuclease fusions and methodsRESOLVE THERAPEUTICS LLC·Filed 2021·Granted Sep 3, 2024·0 cites·28 claims
- 0664US12163165B2Nucleic acid molecules encoding nuclease-albumin fusion proteinsRESOLVE THERAPEUTICS LLC·Filed 2021·Granted Dec 10, 2024·0 cites·57 claims
- 0750US2023355722A1Treatment of sjogren’s syndrome with nuclease fusion proteinsRESOLVE THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 0848US2019241878A1Optimized binuclease fusions and methodsRESOLVE THERAPEUTICS LLC·Filed 2017·Application pending·0 cites
- 0944US2022089786A1Treatment of sjogren's disease with nuclease fusion proteinsRESOLVE THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →